Literature DB >> 19829074

p27 as Jekyll and Hyde: regulation of cell cycle and cell motility.

Michelle D Larrea1, Seth A Wander, Joyce M Slingerland.   

Abstract

p27 is a key regulator of cell proliferation. While it opposes cell cycle progression by binding to and inhibiting cyclin E-Cdk2, T157/T198 phosphorylation of p27 promotes its assembly of D-type cyclin-CDKs. In addition to its actions on the cell cycle, p27 regulates CDK-independent cytoplasmic functions. In human cancers, oncogenic activation of the PI3K signaling pathway often results in cytoplasmic mislocalization of p27. Cytoplasmic p27 plays an important role in cell motility and migration; it binds RhoA and modulates activation of the RhoA/ROCK cascade. p27:RhoA binding is facilitated by p27 phosphorylation at threonine 198. Accumulation of cytoplasmic p27 leads to increased cellular motility, a critical event in tumor metastasis. Further characterization of post-translational modifications governing p27 localization and its action on RhoA and the actin cytoskeleton may provide critical insights into human cancer metastasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19829074     DOI: 10.4161/cc.8.21.9789

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  56 in total

1.  EphB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion.

Authors:  Arend H Sikkema; Wilfred F A den Dunnen; Esther Hulleman; Dannis G van Vuurden; Guillermo Garcia-Manero; Hui Yang; Frank J G Scherpen; Kim R Kampen; Eelco W Hoving; Willem A Kamps; Sander H Diks; Maikel P Peppelenbosch; Eveline S J M de Bont
Journal:  Neuro Oncol       Date:  2012-06-21       Impact factor: 12.300

Review 2.  Primary cilia and coordination of receptor tyrosine kinase (RTK) signalling.

Authors:  Søren T Christensen; Christian A Clement; Peter Satir; Lotte B Pedersen
Journal:  J Pathol       Date:  2011-11-21       Impact factor: 7.996

3.  The CRM1 nuclear export protein in normal development and disease.

Authors:  Kevin T Nguyen; Michael P Holloway; Rachel A Altura
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

4.  Ataxia telangiectasia mutated (ATM) inhibition transforms human mammary gland epithelial cells.

Authors:  Stefano J Mandriota; Raphaële Buser; Laurence Lesne; Christelle Stouder; Vincent Favaudon; Pierre Maechler; Frédérique Béna; Virginie Clément; Curzio Rüegg; Roberto Montesano; André-Pascal Sappino
Journal:  J Biol Chem       Date:  2010-02-22       Impact factor: 5.157

5.  New light on p27(kip1) in breast cancer.

Authors:  Barbara Belletti; Gustavo Baldassarre
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

Review 6.  Cell cycle, cytoskeleton dynamics and beyond: the many functions of cyclins and CDK inhibitors.

Authors:  Nawal Bendris; Bénédicte Lemmers; Jean Marie Blanchard
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

7.  From biological mechanisms to clinical implications: the role of mineral dust-induced gene in lung cancers.

Authors:  Jianjun Zhang; Hongwen Zhao
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

8.  PD-1 inhibits T cell proliferation by upregulating p27 and p15 and suppressing Cdc25A.

Authors:  Nikolaos Patsoukis; Duygu Sari; Vassiliki A Boussiotis
Journal:  Cell Cycle       Date:  2012-10-03       Impact factor: 4.534

9.  microRNA Regulation and Its Consequences in Cancer.

Authors:  Sonya Parpart; Xin Wei Wang
Journal:  Curr Pathobiol Rep       Date:  2012-12-18

10.  JAB1/CSN5: a new player in cell cycle control and cancer.

Authors:  Terry J Shackleford; Francois X Claret
Journal:  Cell Div       Date:  2010-10-18       Impact factor: 5.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.